The AutoCRAT consortium is composed of leading European scientific teams in regenerative medicine, osteoarthritis (OA), preclinical efficacy and safety demonstration, GMP- and GAMP-compliant manufacturing of MSCsPlastic-adherent cells that can be isolated from bone marrow, adipose, and other tissue sources. These cells have the capacity to differentiate into bone cells, cartilage cells, muscle cells and fat cells. Studies have shown MSC may have therapeutic effects through their secretome., clinical trials for OA, regulatory affairs and health economics analysis.
The AutoCRAT Project includes 10 partners from 5 different European countries. Click on a partner logo to access more information about the partner and their team.